On Dihydroorotate Dehydrogenases and Their Inhibitors and Uses

Cited by (236)

Items 101–200 of 236

1. High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
   Marianne Lucas‐Hourani, Hélène Munier‐Lehmann, Olivier Helynck, Anastassia V. Komarova, Philippe Desprès, Frédéric Tangy, Pierre‐Olivier Vidalain · 2014 · Journal of Visualized Experiments
2. The mechanistic study of Leishmania major dihydro-orotate dehydrogenase based on steady- and pre-steady-state kinetic analysis
   Renata A.G. Reis, Patrícia Ferreira, Milagros Medina, Maria Cristina Nonato · 2015 · Biochemical Journal
3. Repurposed dihydroorotate dehydrogenase inhibitors with efficacy against drug-resistant Acinetobacter baumannii
   Thomas A. Russo, Timothy C. Umland, Xiaoyi Deng, Farah El Mazouni, Sreekanth Kokkonda, Ruth Olson, Ulrike MacDonald, Janet M. Beanan, Cassandra L. Alvarado, Diana R. Tomchick et al. · 2022 · Proceedings of the National Academy of Sciences
4. Evaluation of solvent and ion effects upon leflunomide adsorption characteristics on (6,0) zigzag single-walled carbon nanotube and immobilized dihydroorotate dehydrogenase activity: A computational DFT and experimental study
   Fariba Mollania, ‪Heidar Raissi · 2017 · Journal of Molecular Liquids
5. Global Metabolomics in Allogeneic Hematopoietic Cell Transplantation Recipients Discordant for Chronic Graft-versus-Host Disease
   Debra Lynch Kelly, Nosha Farhadfar, Angela Renee Starkweather, Timothy J. Garrett, Yingwei Yao, John R. Wingard, Iqbal Mahmud, Victoria S. Menzies, Param Patel, Karima M. Alabasi et al. · 2020 · Transplantation and Cellular Therapy
6. Leflunomide: Traditional immunosuppressant with concurrent antiviral effects
   Kunyu Zheng, Yiran Chen, Suying Liu, Chengmei He, Yunjiao Yang, Di Wu, Li Wang, Mengtao Li, Xiaofeng Zeng, Fengchun Zhang · 2022 · International Journal of Rheumatic Diseases
7. Compartmentalized cell envelope biosynthesis in Mycobacterium tuberculosis
   Júlia Puffal, Ian L. Sparks, James R. Brenner, Xuni Li, John Leszyk, Jennifer M. Hayashi, Scott A. Shaffer, Yasu S. Morita · 2025 · mBio
8. Assessing risks of multiple sclerosis therapies
   Valeriy Parfenov, Myriam Schluep, Renaud Du Pasquier · 2013 · Journal of the Neurological Sciences
9. An expert overview of emerging therapies for acute myeloid leukemia: novel small molecules targeting apoptosis, p53, transcriptional regulation and metabolism
   Kapil Saxena, Marina Y Konopleva · 2020 · Expert Opinion on Investigational Drugs
10. Structure-based design of potent human dihydroorotate dehydrogenase inhibitors as anticancer agents
    Wenlin Song, Shiliang Li, Yi Tong, Jiawei Wang, Lina Quan, Zhuo Chen, Zhenjiang Zhao, Yufang F. Xu, Lili Zhu, Xuhong H. Qian et al. · 2016 · MedChemComm
11. Concise synthesis and antibacterial evaluation of novel 3‐(1,4‐disubstituted‐1,2,3‐triazolyl)uridine nucleosides
    Hamza Tachallait, Abdelhakim Bouyahya, Aicha Talha, Youssef Bakri, Nadia Dakka, Luc Demange, Rachid Benhida, Khalid Bougrin · 2018 · Archiv der Pharmazie
12. A QM/MM Free Energy Study of the Oxidation Mechanism of Dihydroorotate Dehydrogenase (Class 1A) fromLactococcus lactis
    José Rogério A. Silva, Adrián E. Roitberg, Cláudio Nahum Alves · 2015 · The Journal of Physical Chemistry B
13. Enabling desaturation of lactones by reversible catalytic activity of ‘ene’-reductases
    Fengxi Li, Yihang Dai, Shenhan Xie, Xiaoye Yu, Xinyan Shi, Zhengqiang Li, Chuang Du, Zhi Wang, Lei Wang · 2025 · Green Chemistry
14. A carboxylic acid isostere screen of the DHODH inhibitor Brequinar
    Lindsey G. DeRatt, E. Christine Pietsch, Alexandra Tanner, Paul L. Shaffer, Edgar Jacoby, Weixue Wang, Faraz Kazmi, Xiaochun Zhang, Ricardo M. Attar, James P. Edwards et al. · 2020 · Bioorganic & Medicinal Chemistry Letters
15. Molecular Targets of Ascochlorin and Its Derivatives for Cancer Therapy
    Jason Chua Min‐Wen, Benjamin Yan-Jiang Chua, Srishti Mishra, Xiaoyun Dai, Junji Magae, Ng Shyh‐Chang, Alan Prem Kumar, Gautam Sethi · 2017 · Advances in protein chemistry and structural biology
16. Dihydroorotate Dehydrogenase as a Target for the Development of Novel Helicobacter pylori-Specific Antimicrobials
    Tomokazu Ohishi, D.K. Inaoka, Kiyoshi Kita, Manabu Kawada · 2018 · Chemical and Pharmaceutical Bulletin
17. A novel series of human dihydroorotate dehydrogenase inhibitors discovered by in vitro screening: inhibition activity and crystallographic binding mode
    Ting Zeng, Zeping Zuo, Youfu Luo, Yinglan Zhao, Yamei Yu, Qiang Chen · 2019 · FEBS Open Bio
18. Synthetic Retinoids as Potential Therapeutics in Prostate Cancer—An Update of the Last Decade of Research: A Review
    Przemysław Hałubiec, Agnieszka Łazarczyk, Oskar Szafrański, Torsten Bohn, Joanna Dulińska-Litewka · 2021 · International Journal of Molecular Sciences
19. Identification of Dihydroorotate Dehydrogenase Inhibitors─Indoluidins─That Inhibit Cancer Cell Growth
    Makoto Kawatani, Harumi Aono, Takeshi Shimizu, Shouta Ohkura, Sayoko Hiranuma, Makoto Muroi, Naoko Ogawa, Tomokazu Ohishi, Shun‐ichi Ohba, Manabu Kawada et al. · 2021 · ACS Chemical Biology
20. The Literature of Heterocyclic Chemistry, Part XIII, 2012–2013
    Leonid I. Belen’kii, Yu. B. Evdokimenkova · 2015 · Advances in heterocyclic chemistry
21. Synthesis, structure–activity relationship and binding mode analysis of 4-thiazolidinone derivatives as novel inhibitors of human dihydroorotate dehydrogenase
    Fanxun Zeng, Tiantian Qi, Chunyan Li, Tingfang Li, Honglin Li, Shiliang Li, Lili Zhu, Xiaoyong Xu · 2017 · MedChemComm
22. Design, synthesis, crystal structure andin vitrocytotoxic properties of a novel Schiff base derived from indole and biphenyl
    Fan-Zhi Bu, Xue-Jie Tan, Dian-Xiang Xing, Chao Wang · 2017 · Acta Crystallographica Section C Structural Chemistry
23. Design, Synthesis, and Biological Evaluation of a Novel Series of Teriflunomide Derivatives as Potent Human Dihydroorotate Dehydrogenase Inhibitors for Malignancy Treatment
    Chungen Li, Xiaowei Yang, Yuan Luo, Huan Liu, Xi Zoë Zhong, Xia Zhou, Ting Zeng, Lei Tao, Yue Zhou, Kun Gou et al. · 2021 · Journal of Medicinal Chemistry
24. Novel fungicide quinofumelin shows selectivity for fungal dihydroorotate dehydrogenase over the corresponding human enzyme
    Norikazu Higashimura, Akira Hamada, Shinichi Banba · 2023 · Journal of Pesticide Science
25. A novel series of teriflunomide derivatives as orally active inhibitors of human dihydroorotate dehydrogenase for the treatment of colorectal carcinoma
    Chungen Li, Yue Zhou, Jing Xu, Xia Zhou, Zongkai Huang, Ting Zeng, Xiaowei Yang, Lei Tao, Kun Gou, Xi Zoë Zhong et al. · 2022 · European Journal of Medicinal Chemistry
26. ML390 inhibits enterovirus 71 replication by targeting de novo pyrimidine biosynthesis pathway
    Qingyu Yang, Chengyuan Wu, Guangyan Zhu, Fuli Ren, Binbin Lin, Rui Huang, Xujuan Hu, Dingran Zhao, Ke Peng, Ying Wu et al. · 2022 · Antiviral Research
27. Synthesis and Characterization of DHODH Inhibitors Based on the Vidofludimus Scaffold with Pronounced Anti‐SARS‐CoV‐2 Activity
    Christian Gege, Friedrich Hahn, Christina Wangen, Sigrun Häge, Alexandra Herrmann, Nadja Uhlig, Valentina Eberlein, Leila Issmail, Robert Klopfleisch, Thomas Grünwald et al. · 2024 · ChemMedChem
28. Low cytotoxic quinoline-4-carboxylic acids derived from vanillin precursors as potential human dihydroorotate dehydrogenase inhibitors
    Milena M. Petrović, Cornelia Roschger, Sidrah Chaudary, Andreas F. Zierer, Milan P. Mladenović, Violeta R. Marković, Snežana S. Trifunović, Milan D. Joksović · 2021 · Bioorganic & Medicinal Chemistry Letters
29. New Insights into the Interaction of Class II Dihydroorotate Dehydrogenases with Ubiquinone in Lipid Bilayers as a Function of Lipid Composition
    Juan Manuel Orozco Rodriguez, Hanna Pauliina Wacklin, Luke A. Clifton, Oliver Bogojevic, Anna E. Leung, Giovanna Fragneto, Wolfgang Knecht · 2022 · International Journal of Molecular Sciences
30. A Patent Review of Human Dihydroorotate Dehydrogenase (hDHODH) Inhibitors as Anticancer Agents and their Other Therapeutic Applications (1999-2022)
    Pinky Gehlot, Vivek Kumar Vyas · 2023 · Recent Patents on Anti-Cancer Drug Discovery
31. A high-throughput fluorescence-based assay for Plasmodium dihydroorotate dehydrogenase inhibitor screening
    Iván Caballero, María José Lafuente, Francisco‐Javier Gamo, Concepción Cid · 2016 · Analytical Biochemistry
32. Classical swine fever virus non-structural protein 4A recruits dihydroorotate dehydrogenase to facilitate viral replication
    Bing-qian Zhao, Jing Chen, Jinxia Chen, Yan Fen Cheng, Jiang-fei Zhou, Ji-shan Bai, Ding-yi Mao, Bin Zhou · 2024 · Journal of Virology
33. Activation de la réponse innée antivirale par des inhibiteurs de la biosynthèse des pyrimidines
    Pierre‐Olivier Vidalain, Marianne Lucas‐Hourani, Olivier Helynck, Frédéric Tangy, Hélène Munier‐Lehmann · 2015 · médecine/sciences
34. Leflunomide triggers synthetic lethality in PTEN-deficient prostate cancer
    Sait Ozturk, Deepti Mathur, Royce W. Zhou, David J. Mulholland, Ramon E. Parsons · 2020 · Prostate Cancer and Prostatic Diseases
35. A novel and potent dihydroorotate dehydrogenase inhibitor suppresses the proliferation of colorectal cancer by inducing mitochondrial dysfunction and DNA damage
    Xiaowei Yang, Chungen Li, Kun Gou, Xiaocong Liu, Yue Zhou, Jiao Zou, Qiang Chen, Youfu Luo, Yinglan Zhao · 2022 · MedComm – Oncology
36. Crystal structures of FMN ‐bound and FMN ‐free forms of dihydroorotate dehydrogenase from Trypanosoma brucei
    Tomomi Kubota, Osamu Tani, Tomohiko Yamaguchi, Ichiji Namatame, Hitoshi Sakashita, Koji Furukawa, Kazuhiko Yamasaki · 2018 · FEBS Open Bio
37. Discovery of potent human dihydroorotate dehydrogenase inhibitors based on a benzophenone scaffold
    Chungen Li, Yue Zhou, Jing Xu, Xia Zhou, Song Liu, Zongkai Huang, Zhiqiang Qiu, Ting Zeng, Kun Gou, Lei Tao et al. · 2022 · European Journal of Medicinal Chemistry
38. Anti-Trypanosoma cruzi activity of Coptis rhizome extract and its constituents
    Yuki Tayama, Shusaku Mizukami, Kazufumi Toume, Katsuko Komatsu, Tetsuo Yanagi, Takeshi Nara, Thuan Minh Tieu, Nguyen Tien Huy, Shinjiro Hamano, Kenji Hirayama · 2023 · Tropical Medicine and Health
39. Medicinal Chemistry Approaches for the Discovery of Plasmodium Falciparum Dihydroorotate Dehydrogenase Inhibitors as Antimalarial Agents
    Vivek Kumar Vyas, Tanvi Shukla, Manmohan Sharma · 2023 · Future Medicinal Chemistry
40. Discovery and Optimization of Novel hDHODH Inhibitors for the Treatment of Inflammatory Bowel Disease
    Xia Zhou, Kun Gou, Jing Xu, Lunan Jian, Yuan Luo, Chungen Li, Xinqi Guan, Jiahao Qiu, Jiao Zou, Yu Zhang et al. · 2023 · Journal of Medicinal Chemistry
41. NK-A 17E-233I: a novel competitive inhibitor of human dihydroorotate dehydrogenase (DHODH) for cancer therapy
    Mohammed Moustapha Anwar, Salvador Meseguer, Néstor García‐Rodríguez, Ewa Krupinska, Céleste Sèle, Aida Rodríguez-Jiménez, Suraj Verma, Samna Sagadevan, Javier Ramón, Ramón Martí et al. · 2025 · Journal of Experimental & Clinical Cancer Research
42. On drug discovery against infectious diseases and academic medicinal chemistry contributions
    Yves Louis Janin · 2022 · Beilstein Journal of Organic Chemistry
43. Dihydroorotate dehydrogenase as a herbicide target
    Stephen Oscar Duke · 2023 · Proceedings of the National Academy of Sciences
44. Screening for DAX1 / EWS‐FLI1 functional inhibitors identified dihydroorotate dehydrogenase as a therapeutic target for Ewing's sarcoma
    Miwa Watanabe, Hiromichi Kosaka, Masamori Sugawara, Michihiro Maemoto, Yoko Ono, Takeshi Uemori, Ryota Shizu, Kouichi Yoshinari · 2023 · Cancer Medicine
45. Evaluation of WO2013076170: the use of a dihydroorotate dehydrogenase inhibitor for the treatment of psoriasis
    Peter Norman · 2013 · Expert Opinion on Therapeutic Patents
46. Synthesis, structure and antiproliferative and optical activities of two new biphenyl-derived Schiff bases
    Xue-Jie Tan, Ling-Yao Zhang, Yuan-Kai Sun, Xue-Min Zhou · 2019 · Acta Crystallographica Section C Structural Chemistry
47. Pivotal role of dihydroorotate dehydrogenase as a therapeutic target in adult T‐cell leukemia
    Chie Ishikawa, Naoki Mori · 2024 · European Journal Of Haematology
48. Drug Design Strategies, Modes of Action, Synthesis and Industrial Challenges Behind Trifluoromethylated New Chemical Entities
    Leitao EPT, Sobral LMS · 2024 · Journal of Biomedical Research & Environmental Sciences
49. Ene‐Reductase‐Catalyzed Aromatization of Simple Cyclohexanones to Phenols
    Jie Chen, Shaofang Qi, Zhiguo Wang, Liran Hu, Jialing Liu, Guixiang Huang, Yongzhen Peng, Zheng Dong Fang, Qi Wu, Yujing Hu et al. · 2024 · Angewandte Chemie
50. Intrinsic Natural Resistance of Various Plant Pathogens to Ipflufenoquin, a New DHODH (Dihydroorotate Dehydrogenase)-Inhibiting Fungicide, in Relation to an Unaltered Amino Acid Sequence of the Target Site
    Hideo Ishii, Izumi Okane, Yuichi Yamaoka · 2024 · Plant Disease
51. Accelerating drug discovery targeting dihydroorotate dehydrogenase using machine learning and generative AI approaches
    Gayathri Krishnamurthy Ganga · 2025 · Computational Biology and Chemistry
52. In silico Molecular Docking Analysis of Three Molecules Isolated from Litsea guatemalensis Mez on Anti-inflammatory Receptors
    Lucrecia Peralta, Allan Vásquez, Nereida Marroquín, Lesbia Guerra, Sully Margot Cruz, Armando Cáceres · 2023 · Combinatorial Chemistry & High Throughput Screening
53. Medicinal Chemistry Case History: Discovery of the Dihydroorate Dehydrogenase Inhibitor DSM265 as an Antimalarial Drug Candidate
    Margaret A. Phillips, Pradipsinh K. Rathod, Thomas Rueckle, D. Matthews, Jeremy Nicholas Burrows, Susan A. Charman · 2016 · Elsevier eBooks
54. Sequence Similarity Network Guided Discovery of a Dehydrogenase for Asymmetric Carbonyl Dehydrogenation
    Yujing Hu, Jie Chen, Shaofang Qi, Hui Wang, Zhaoxuan Zhu, Yongzhen Peng, Wenjing Wang, Guixiang Huang, Zheng Dong Fang, Yuxuan Ye et al. · 2025 · Angewandte Chemie
55. Phenotypical Screening of an MMV Open Box Library and Identification of Compounds with Antiviral Activity against St. Louis Encephalitis Virus
    Giuliana Eboli Sotorilli, Humberto Doriguêtto Gravina, Ana Carolina de Carvalho, Jacqueline Farinha Shimizu, Marina Alves Fontoura, Talita Diniz Melo‐Hanchuk, Artur T. Cordeiro, Rafael Elias Marques · 2023 · Viruses
56. Crystal structure of dihydroorotate dehydrogenase from Helicobacter pylori with bound flavin mononucleotide
    Ashna A. Agarwal, John D. Georgiades, David M. Dranow, Donald D. Lorimer, Thomas E. Edwards, Kayleigh F. Barrett, Justin K. Craig, Wesley C. Van Voorhis A, Peter John Myler, Craig L. Smith · 2025 · Acta Crystallographica Section F Structural Biology Communications
57. Management of disease-modifying therapies in multiple sclerosis and comorbid rheumatoid arthritis
    Franz Felix Konen, Torsten Witte, Diana Ernst, David Hagin, Konstantin Fritz Jendretzky, Nora Möhn, Sandra Nay, Lea Martha Grote-Levi, Kurt‐Wolfram Sühs, Luisa Klotz et al. · 2025 · Neurological Research and Practice
58. N-phenyl ureidobenzenesulfonates, a novel class of promising human dihydroorotate dehydrogenase inhibitors
    Chahrazed Bouzriba, Lauriane Larcher, Mathieu Gagné‐Boulet, Sébastien Fortin · 2020 · Bioorganic & Medicinal Chemistry
59. Lifting the Differentiation Embargo
    Anne‐Louise Latif, Tessa L. Holyoake · 2016 · Cell
60. Antimalarial drugs
    Benjamin J. Sawyer, Md Imdadul H. Khan, Hoang V. Le · 2023 · Elsevier eBooks
61. Tiratricol, a thyroid hormone metabolite, has potent inhibitory activity against human dihydroorotate dehydrogenase
    Shuying Cao, Hui Ma, Zhaomin Xu, Wenqing Fang, Jin Yan Huang, Ying Huang · 2023 · Chemical Biology & Drug Design
62. QSAR and molecular docking studies on 4-quinoline carboxylic acid derivatives as inhibition of vesicular stomatitis virus replication
    Tawassl Tajelsir Hassan Hajalsiddig, A. E. M. Saeed · 2019 · European Journal of Chemistry
63. Structural Optimization and Structure–Activity Relationship of 4-Thiazolidinone Derivatives as Novel Inhibitors of Human Dihydroorotate Dehydrogenase
    Fanxun Zeng, Lina Quan, Guantian Yang, Tiantian Qi, Letian Zhang, Shiliang Li, Honglin Li, Lili Zhu, Xiaoyong Xu · 2019 · Molecules
64. Chemical Constituents from Chloranthus elatior and Their Inhibitory Effect on Human Dihydroorotate Dehydrogenase
    Qian Yang, An Jia, Xizi Liu, Shiyi Han, Siyang Fan · 2021 · Planta Medica
65. Synthesis of Potential Inhibitors Targeting Dihydroorotate Dehydrogenase as Herbicide Candidates
    Wenfei Wang, Lijia Di, Luyang Tian, Jingqian Huo, Zexiu An, Jinlin Zhang, Lai Chen · 2025 · Journal of Agricultural and Food Chemistry
66. Exploring quinone‐binding sites as targets for pesticides
    Shinichi Banba · 2025 · Pest Management Science
67. Development of a machine learning‐based target‐specific scoring function for structure‐based binding affinity prediction for human dihydroorotate dehydrogenase inhibitors
    Jinhui Meng, Li Zhang, Zhe He, Mengfeng Hu, Jinhan Liu, Wenzhuo Bao, Qifeng Tian, Huawei Feng, Hongsheng Liu · 2024 · Journal of Computational Chemistry
68. Development of a biomarker to monitor target engagement after treatment with dihydroorotate dehydrogenase inhibitors
    Michael A. Pontikos, Christopher Leija, Zhiyu Zhao, Xiaoyu Wang, Jessica A. Kilgore, Belen M. Tornesi, Nicole Adenmatten, Margaret A. Phillips, Noelle Sevilir Williams · 2022 · Biochemical Pharmacology
69. Small-Molecule Strategies against Human Adenoviruses: Progress, Challenges, and Future Perspectives
    Jingwen Huo, Haiying Chen, Xinhui Qiu, Ge Wang, Javier Sánchez‐Céspedes, Kuancheng Liu, Jia Zhou, Jimin Xu · 2025 · Journal of Medicinal Chemistry
70. Inhibitors of pyrimidine synthesis synergize with N4-hydroxycytidine to diminish influenza virus replication
    Leon Schrell, David Scheibner, Antje Dickmanns, Kim M. Stegmann, Lukas Mathias Michaely, Annika Graaf-Rau, Philip A. Beer, Andrew Parker, Sandra Diederich, Anne Balkema‐Buschmann et al. · 2025 · Antiviral Research
71. Lapachol, a dihydroorotate dehydrogenase inhibitor, demonstrates antiviral activity against feline calicivirus in vitro and in vivo
    Zexin Liu, Guohong Albert Wu, Jianwei Mao, Yutong Zheng, Qizhen Fu, Sifan Lin, Y L CHEN, Weisan Chen, Pei Zhou, Jianxin Chen · 2026 · Antiviral Research
72. Antiviral activities of ascofuranone and naphthoquinone derivatives against Ebola virus
    Christelle M. Pemba, Yasuteru Sakurai, Yohei Kurosaki, J. J. Patten, Eri Amalia, D.K. Inaoka, Robert A. Davey, T. Shiba, Kiyoshi Kita, Jiro Yasuda · 2026 · Antiviral Research
73. Contribution of dihydroorotate dehydrogenase complex to NADH supply and metabolic flux redirection in Clostridium acetobutylicum
    Dandan Jiang, Jihong Yi, Haifeng Zhu, Liangliang Gao, Shuning Wang, Guodong Liu, 李澜鹏, Quan Zhang, MENG WANG, Armin Ehrenreich et al. · 2026 · Bioresource Technology
74. A ferredoxin-dependent dihydropyrimidine dehydrogenase in Clostridium chromiireducens
    Feifei Wang, Yifeng Wei, Qiang Lü, Ee Lui Ang, Huimin Zhao, Yan Zhang · 2020 · Bioscience Reports
75. Photochemical Desaturation and Epoxidation with Oxygen by Sequential Flavin Catalysis
    Alexandra Walter, Wolfgang Eisenreich, Golo Storch · 2023 · Angewandte Chemie
76. Discovery of Nanomolar Inhibitors for Human Dihydroorotate Dehydrogenase Using Structure-Based Drug Discovery Methods
    William T. Higgins, Sandip M. Vibhute, Chad E. Bennett, Steffen Lindert · 2024 · Journal of Chemical Information and Modeling
77. IPP/CNRS-A017: A chemical probe for human dihydroorotate dehydrogenase (hDHODH)
    Andreas Krämer, Amelie Tjaden, Benardina Ndreshkjana, Claudia Tredup, Henner F. Farin, Stefan Knapp, Yves Louis Janin, Susanne Müller · 2022 · Current Research in Chemical Biology
78. Biological evaluation of quinoline derivatives as inhibitors of human dihydroorotate dehydrogenase
    Jiawei Wang, Yanyan Diao, Junsheng Zhu, Shiliang Li, Zhenjiang Zhao, Honglin Li, Lili Zhu · 2016 · MedChemComm
79. Evaluation of Cardiospermum halicacabum leaf compounds against human DihydroOrotate Dehydrogenase: a target for Rheumatoid Arthritis using Structure based Drug Designing
    Priya Swaminathan, Lilly M. Saleena · 2017 · Journal of Applied Pharmaceutical Science
80. A Bioinformatics Analysis and Homology 3D Modeling of Dihydroxy-orotate-dehydrogenase of Plasmodium ovale
    Rudi Nirwantono, Khoirunnisa Assidqi, Alam Ahmad Hidayat, Joko Pebrianto Trinugroho, Bens Pardamean · 2023 · International Conference on Informatics, Multimedia, Cyber and Information System (ICIMCIS)
81. Síntese de inibidores das enzimas cruzaína e diidroorotato desidrogenase de Trypanosoma cruzi
    Leandro A. Alves Avelar · 2014
82. Identifizierung und Charakterisierung der Dihydroorotat Dehydrogenase als Zielstruktur von 1-Hydroxyquinolonen in Toxoplasma gondii
    Jana Hegewald · 2014
83. Desenvolvimento de uma plataforma modelo para a busca de ligantes com potencial leishmanicida baseado na inibição seletiva da enzima diidroorotato desidrogenase
    Eder Júnior Lorenzato · 2016
84. Determinação do modo de interação de inibidores reversíveis da cruzaína de Trypanosoma cruzi via cristalografia de raios X
    W.B. Fernandes · 2015
85. Synthesis of novel PfDHODH inhibitors based on 4-aminocoumarin structures
    Federico Valerio · 2016 · Lund University Publications Student Papers (Lund University)
86. E-pharmacophore screening and induced fit docking of phytocompounds against human dihydroorotate dehydrogenase
    Priya Swaminathan · 2017 · International Journal of Pharma and Bio Sciences
87. Triagem de inibidores da enzima DHODH de Leishmania major em Asteraceae: estudos metabolômicos e da relação estrutura-atividade quantitativa (QSAR)
    Lucas Apolinário Chibli · 2018
88. Reposicionamento de drogas antimaláricas no tratamento da esquistossomose baseado na inibição seletiva da enzima diidroorotato desidrogenase
    Felipe A. Calil · 2019
89. Reposicionamento de fármacos para o tratamento da doença de Chagas: desenvolvimento de modelos computacionais baseados em ligantes ativos fenotipicamente contra o Trypanosoma cruzi e na inibição da diidroorotato desidrog
    Marcos Antonio Ferreira · 2021 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
90. Analysis of teriflunomide therapy on EAE
    Dannheim Jasemin · 2022
91. Exploring Phytophthora agathidicida Oospore Viability and Germination
    Fairhurst, Michael · 2023
92. Desenvolvimento de um ensaio fenotípico para triagem de alta performance de compostos protetores contra a infecção pelo vírus da encefalite de St. Louis
    Giuliana Eboli Sotorilli · 2022
93. PENDEKATAN KOMPUTASI UNTUK MENGATASI MALARIA DARI Coscinium fenestratum
    Universitas Lambung Mangkurat, Samsul Hadi, Kunti Nastiti, Prodi S1 Farmasi, Fakultas Kesehatan, Universitas Sari Mulia · 2023 · Jurnal Insan Farmasi Indonesia
94. Additional file 1 of Anti-Trypanosoma cruzi activity of Coptis rhizome extract and its constituents
    Yuki Tayama, Shusaku Mizukami, Kazufumi Toume, Katsuko Komatsu, Tetsuo Yanagi, Takeshi Nara, Paul Tieu, Huy, Nguyen Tien, Hamano, Shinjiro, Hirayama, Kenji · 2023 · Figshare
95. Design, Construction, and Efficacy of a Novel Multiepitope Chimeric Vaccine Against Lumpfish (Cyclopterus lumpus) Infection
    Joy Chukwu-Osazuwa, Trung Cao, Ignacio Vásquez, Hajarooba Gnanagobal, Ahmed Hossain, Oluwatoyin Onireti, Setu Chakraborty, Vimbai Irene Machimbirike, Javier Santander · 2026 · Fishes
96. In silico Optimization of Dihydroorotate dehydrogenase Inhibitors for Malaria viaDocking, Molecular Dynamics, and ADMET Evaluation
    Simon Mugisa, Lalitha Bhaskarini Dyvapu, Tuyizere Rebecca, Uwase Shema Christelle, Hekmatullah Nang, Dora Mallikharjuna Sarma Mamillapalli, Narayana Murthy Ganta, Naresh Dumala, Manikanta Murahari · 2026 · Discover Molecules
97. Multiple Sklerose und rheumatoide Arthritis: Überschneidungen und Interferenzen bei den Therapiekonzepten
    Franz Felix Konen, Torsten Witte, Marc Pawlitzki, Sven G. Meuth, Thomas Skripuletz · 2026 · Deutsches Ärzteblatt
98. Nucleic acid metabolism as therapeutic target in cancer: a comprehensive analysis of folate cycle, nucleotide synthesis, and clinical applications
    Jacinta DSouza, Harish Kundaikar · 2026 · Elsevier eBooks
99. Manipulation of nucleotides by the obligate intracellular bacterium Chlamydia trachomatis
    Laure Blanchet · 2024
100. Dihydroorotate dehydrogenase: A multifunctional target in cancer, infectious diseases, and immune disorders
     Xiaoying Guan, Jinchun Li, Xiaoli Guan, Cuirong Hao, Yajie Zhang, Hong Yan · 2026 · The International Journal of Biochemistry & Cell Biology